Toprol
NDC Package 0186-1092-35
Package Information
Toprol is a medication a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Marketed by Astrazeneca Pharmaceuticals Lp, this product is identified by NDC 0186-1092 and is authorized under FDA application NDA019962.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0186 - Astrazeneca Pharmaceuticals Lp
- 0186-1092 - Toprol
- 0186-1092-35 - 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 0186-1092 - Toprol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0186-1092). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0186-1092-35 identifies a specific commercial package of 1000 tablet, extended release in 1 bottle of Toprol XL, labeled by Astrazeneca Pharmaceuticals Lp. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Astrazeneca Pharmaceuticals Lp on February 01, 1992. The current certification is valid through July 31, 2021.
What are the primary indications for this medication?
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.
How is this Astrazeneca Pharmaceuticals Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00186109235. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.